TRIMETHOBENZAMIDE HYDROCHLORIDE - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for trimethobenzamide hydrochloride and what is the scope of patent protection?

Trimethobenzamide hydrochloride is the generic ingredient in three branded drugs marketed by King Pharms Llc, Avet Lifesciences, Lupin, Sun Pharm Industries, Endo Operations, Am Regent, Hospira, Smith And Nephew, Solopak, and Watson Labs, and is included in thirteen NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for trimethobenzamide hydrochloride. Nine suppliers are listed for this compound.

Sponsor

Phase

Indiana University

Phase 2

Kyowa Kirin

Phase 2

Pfizer

Phase 1

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Am Regent	TRIMETHOBENZAMIDE HYDROCHLORIDE	trimethobenzamide hydrochloride	INJECTABLE;INJECTION	091330-001	Mar 8, 2011		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Avet Lifesciences	TRIMETHOBENZAMIDE HYDROCHLORIDE	trimethobenzamide hydrochloride	CAPSULE;ORAL	205950-001	Nov 21, 2023	AB	RX	No	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Lupin	TRIMETHOBENZAMIDE HYDROCHLORIDE	trimethobenzamide hydrochloride	CAPSULE;ORAL	076546-001	Aug 20, 2003	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Solopak	TRIMETHOBENZAMIDE HYDROCHLORIDE	trimethobenzamide hydrochloride	INJECTABLE;INJECTION	089094-001	Apr 4, 1986		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Watson Labs	TRIMETHOBENZAMIDE HYDROCHLORIDE	trimethobenzamide hydrochloride	INJECTABLE;INJECTION	086577-001	Oct 19, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Smith And Nephew	TRIMETHOBENZAMIDE HYDROCHLORIDE	trimethobenzamide hydrochloride	INJECTABLE;INJECTION	088960-001	Apr 4, 1986		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

US Patents:	0
Tradenames:	3
Applicants:	10
NDAs:	13
Drug Master File Entries:	3
Finished Product Suppliers / Packagers:	9
Raw Ingredient (Bulk) Api Vendors:	68
Clinical Trials:	4
Patent Applications:	725
What excipients (inactive ingredients) are in TRIMETHOBENZAMIDE HYDROCHLORIDE?	TRIMETHOBENZAMIDE HYDROCHLORIDE excipients list
DailyMed Link:	TRIMETHOBENZAMIDE HYDROCHLORIDE at DailyMed

Drug Class	Antiemetic
Physiological Effect	Emesis Suppression